The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors

The enthusiasm for immune checkpoint inhibitors (ICIs), an efficient tumor treatment model different from traditional treatment, is based on their unprecedented antitumor effect, but the occurrence of immune-related adverse events (irAEs) is an obstacle to the prospect of ICI treatment. IrAEs are a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Jia, Xiao-Hui, Geng, Lu-Ying, Jiang, Pan-Pan, Xu, Hong, Nan, Ke-Jun, Yao, Yu, Jiang, Li-Li, Sun, Hong, Qin, Tian-Jie, Guo, Hui
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7734811/
https://ncbi.nlm.nih.gov/pubmed/33317597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-020-01749-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados